Rituximab, a lower-cost treatment, may be as effective at managing RRMS as the approved therapy Ocrevus, a new study from ...

For Pree, diagnosed with multiple sclerosis at 19, finishing college was a challenge. Still, amidst it all, she decided to open up about her journey by sharing her first video on YouTube. Little did ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

Columnist Desiree Lama shares what she wishes she'd been told after her diagnosis of multiple sclerosis at age 17.

Depression and anxiety have been well documented in people with multiple sclerosis (MS), but often are undiagnosed or ...

Data from an open-label extension of VISIONARY-MS support an association between gold nanocrystals and neuronal repair and remyelination in patients with stable multiple sclerosis and visual deficits, ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called ...

Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive multiple ...

Research published in the Journal of Neurochemistry has detailed the role of a protein, hnRNP A1, in the formation and ...

A University of Alberta study shows that rural Albertans living with multiple sclerosis are not as likely as urban patients ...

Feb. 18, 2025 — A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It ... Dec. 18, 2024 — Many ...

A new study has identified the protein hnRNP A1 as a key player in the production and maintenance of myelin, the fatty sheath ...